To evaluate the potential of SmartDCs technology in BC, we selected FRα as a target TAA for generation of SmartDCs because FRα is highly expressed on BC cells in all molecular subtypes [23], and has low expression in normal breast tissues. Here, FOLR1 is linked to breast cancer.